Document Detail

Patterns of antidepressant medication use among pregnant women in a United States population.
MedLine Citation:
PMID:  20663997     Owner:  NLM     Status:  In-Data-Review    
This article describes the pattern of reported antidepressant use around the time of pregnancy in a population-based sample of women who delivered live-born babies without birth defects. Data were used from the National Birth Defects Prevention Study, an ongoing case-control study of risk factors for birth defects covering 10 US states. Mothers of live-born infants without birth defects (controls) born between 1998 and 2005 were randomly selected from each site. Information on the mother's characteristics and exposure to antidepressants was collected via a standardized telephone interview. Among 6582 mothers included in the study, 298 (4.5%) reported use of an antidepressant in the period of 3 months before through the end of pregnancy. Use of selective serotonin-reuptake inhibitors was reported most often (3.8%), followed by bupropion (0.7%). A statistically significant decline was observed, from 3.1% to 2.3% (P < .001), in reported use of antidepressants between the first and second month after conception. The frequency of reported antidepressant use at any time during pregnancy increased from 2.5% in 1998 to 8.1% in 2005 (P < .001) in 4 states. The findings show an increase in reported antidepressant use over a 9-year period and a substantial decrease in use around the usual time of pregnancy recognition.
Sura Alwan; Jennita Reefhuis; Sonja A Rasmussen; Jan M Friedman;
Related Documents :
9575467 - Contents of childbirth-related fear among couples wishing the partner's presence at del...
7755787 - Suicide during pregnancy and its neglect as a component of maternal mortality.
11097507 - Pregnancy intention and pregnancy happiness: are they different?
22956887 - A molar masquerading as an ectopic pregnancy in the early first trimester: a salutary l...
22536377 - Evaluation of the london measure of unplanned pregnancy in a united states population o...
18240337 - Prenatal diagnosis of cystic fibrosis: the 18-year experience of brittany (western fran...
Publication Detail:
Type:  Journal Article     Date:  2010-07-27
Journal Detail:
Title:  Journal of clinical pharmacology     Volume:  51     ISSN:  1552-4604     ISO Abbreviation:  J Clin Pharmacol     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0366372     Medline TA:  J Clin Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  264-70     Citation Subset:  IM    
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 1600 Clifton Road, MS E-86, Atlanta, GA 30333; e-mail:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Anticoagulation with argatroban for elective percutaneous coronary intervention: population pharmaco...
Next Document:  Clinical and biochemical efficacy of minocycline in nonsurgical periodontal therapy: a randomized co...